|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Asset impairment | |||||
| Operating loss | |||||
| Gain on initial investment in unconsolidated entity | |||||
| Change in fair value of financial instruments | |||||
| Other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Income tax benefit (expense) | |||||
| Net loss | |||||
| Per common share amounts (Note 12) | |||||
| Net loss per common share, basic (in usd per share) | |||||
| Net loss per common share, diluted (in usd per share) | |||||
| Weighted-average shares used in computing net loss per share, basic (in shares) |
Loading...
